Form 4 for MRKR Marker Therapeutics, Inc.
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-24 · accession 0001209191-22-021394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-28 | 2022-03-24 | MRKR | Kim Anthony H. | CFO | A - Grant | $0.00 | +150.5K | 150.5K | New | $0 | |
| 2022-03-28 | 2022-03-24 | MRKR | Kim Anthony H. | CFO | F - Tax | $0.48 | -36.1K | 114.4K | -24% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-24 | A | A | 150,512 | $0.00 | 150,512 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. |
| 2 | Common | Common Stock | 2022-03-24 | F | D | 36,076 | $0.48 | 114,436 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs. |